Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Haferkamp

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
Cancer Immunology, Immunotherapy : CII|June 13, 2019
Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastasesYenny Angela, Sebastian Haferkamp, Carsten Weishaupt, et al.
Molecular & Cellular Proteomics : MCP|November 24, 2016
Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic MelanomaBesnik Muqaku, Martin Eisinger, Samuel M Meier, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2025
Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendationsThomas Koeglsperger, Emir Berberovic, Christian Dresel, et al.
The Journal of Investigative Dermatology|April 9, 2013
Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigensRoland Houben, Christina Dreher, Sabrina Angermeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2023
Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanomaStefanie Meyer, Lorenz Buser, Sebastian Haferkamp, et al.
Journal of Cellular and Molecular Medicine|March 2, 2026
The Influence of Extracellular Citrate in Physiological Concentration on the Proliferation of Malignant MelanomaKonstantin Drexler, Barbara Schwertner, Veronika Zenderowski, et al.
Pigment Cell & Melanoma Research|June 8, 2019
Role of melanoma inhibitory activity in melanocyte senescenceLena Feuerer, Susanne Lamm, Ingmar Henz, et al.
The Journal of Investigative Dermatology|January 17, 2013
Vemurafenib induces senescence features in melanoma cellsSebastian Haferkamp, Andreas Borst, Christian Adam, et al.
Advances in Therapy|December 12, 2018
Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician SurveyPeter Mohr, Sebastian Haferkamp, Andreas Pinter, et al.
International Journal of Cancer|September 19, 2015
Serine 220 phosphorylation of the Merkel cell polyomavirus large T antigen crucially supports growth of Merkel cell carcinoma cellsDavid Schrama, Sonja Hesbacher, Sabrina Angermeyer, et al.
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|June 13, 2019
Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastasesYenny Angela, Sebastian Haferkamp, Carsten Weishaupt, et al.
Molecular & Cellular Proteomics : MCP|November 24, 2016
Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic MelanomaBesnik Muqaku, Martin Eisinger, Samuel M Meier, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2025
Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendationsThomas Koeglsperger, Emir Berberovic, Christian Dresel, et al.
The Journal of Investigative Dermatology|April 9, 2013
Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigensRoland Houben, Christina Dreher, Sabrina Angermeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2023
Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanomaStefanie Meyer, Lorenz Buser, Sebastian Haferkamp, et al.
Journal of Cellular and Molecular Medicine|March 2, 2026
The Influence of Extracellular Citrate in Physiological Concentration on the Proliferation of Malignant MelanomaKonstantin Drexler, Barbara Schwertner, Veronika Zenderowski, et al.
Pigment Cell & Melanoma Research|June 8, 2019
Role of melanoma inhibitory activity in melanocyte senescenceLena Feuerer, Susanne Lamm, Ingmar Henz, et al.
The Journal of Investigative Dermatology|January 17, 2013
Vemurafenib induces senescence features in melanoma cellsSebastian Haferkamp, Andreas Borst, Christian Adam, et al.
Advances in Therapy|December 12, 2018
Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician SurveyPeter Mohr, Sebastian Haferkamp, Andreas Pinter, et al.
International Journal of Cancer|September 19, 2015
Serine 220 phosphorylation of the Merkel cell polyomavirus large T antigen crucially supports growth of Merkel cell carcinoma cellsDavid Schrama, Sonja Hesbacher, Sabrina Angermeyer, et al.
Pageof 15